Page last updated: 2024-11-05

ticlopidine and Arteriovenous Malformations

ticlopidine has been researched along with Arteriovenous Malformations in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Arteriovenous Malformations: Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kilburg, C1
Taussky, P1
Kalani, MY1
Park, MS1
Fujikawa, T1
Maekawa, H1
Shiraishi, K1
Tanaka, A1

Other Studies

2 other studies available for ticlopidine and Arteriovenous Malformations

ArticleYear
Novel use of flow diversion for the treatment of aneurysms associated with arteriovenous malformations.
    Neurosurgical focus, 2017, Volume: 42, Issue:6

    Topics: Adult; Arteriovenous Malformations; Aspirin; Clopidogrel; Embolization, Therapeutic; Female; Humans;

2017
Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.
    BMJ case reports, 2012, Sep-24, Volume: 2012

    Topics: Arteriovenous Malformations; Aspirin; Clopidogrel; Drug-Eluting Stents; Gastrointestinal Hemorrhage;

2012